AstraZeneca sticks to second-half 2015 timetable for new lung cancer pill

MADRID (Reuters) - AstraZeneca said on Saturday it expected to file a new lung cancer pill for U.S. regulatory approval in the second half of 2015, potentially disappointing some investors who had hoped the drug might be ready faster. Analysts at Citi said in a research note this week they believed AZD9291 could be submitted as early as the first quarter of 2015, putting AstraZeneca ahead in a race with Clovis Oncology, which is developing a similar medicine. ...



via Health News Headlines - Yahoo News http://ift.tt/1qGpcoN